2024
Hepatotoxicity Score: A New Method to Adjust for Use of Potentially Hepatotoxic Medications by Chronic Liver Disease Status
Re V, Newcomb C, Carbonari D, Mezochow A, Hennessy S, Rentsch C, Park L, Tate J, Bräu N, Bhattacharya D, Lim J, Mezzacappa C, Njei B, Roy J, Taddei T, Justice A, Torgersen J. Hepatotoxicity Score: A New Method to Adjust for Use of Potentially Hepatotoxic Medications by Chronic Liver Disease Status. Pharmacoepidemiology And Drug Safety 2024, 33: e70069. PMID: 39662972, PMCID: PMC11634562, DOI: 10.1002/pds.70069.Peer-Reviewed Original ResearchConceptsProton pump inhibitor initiationHazard ratioVeterans Health AdministrationSevere acute liver injuryProton pump inhibitorsChronic liver diseaseAcute liver injuryRates of hospitalizationSafety of medicationsPPI initiativesHealth AdministrationLiver disease statusMedication exposurePharmacoepidemiological studiesMedicationConfoundingScoresReports of hepatotoxicityDisease statusHepatotoxic medicationsDrug exposurePump inhibitorsHepatotoxic drugsOutpatient initiationHepatic safety
2018
Efficacy of transoral incisionless fundoplication for refractory gastroesophageal reflux disease: a systematic review and meta-analysis
McCarty T, Itidiare M, Njei B, Rustagi T. Efficacy of transoral incisionless fundoplication for refractory gastroesophageal reflux disease: a systematic review and meta-analysis. Endoscopy 2018, 50: 708-725. PMID: 29625507, DOI: 10.1055/a-0576-6589.Peer-Reviewed Original ResearchConceptsHealth-related quality of lifeRefractory gastroesophageal reflux diseaseGastroesophageal reflux diseaseProton pump inhibitorsGastroesophageal reflux disease health-related quality of lifeReflux Symptom IndexTreatment of refractory gastroesophageal reflux diseaseTransoral incisionless fundoplicationAdverse eventsHernia reductionSystematic reviewEfficacy of transoral incisionless fundoplicationReflux diseaseProton pump inhibitor therapyMeta-analysisHiatal hernia reductionSymptomatic response rateTechnical success rateCochrane Library databasesQuality of lifeSuccess rateAdverse event ratesEffective endoscopic procedureReflux symptom scoreSearch of PubMed
2016
Daily Proton Pump Inhibitors Are Cost-Effective in Reducing BarrettĘĽs Induced Esophageal Adenocarcinoma Mortality: 2016 ACG Presidential Poster Award
Rezaizadeh H, McCarty T, Njei B, Birk J. Daily Proton Pump Inhibitors Are Cost-Effective in Reducing BarrettĘĽs Induced Esophageal Adenocarcinoma Mortality: 2016 ACG Presidential Poster Award. The American Journal Of Gastroenterology 2016, 111: s211. DOI: 10.14309/00000434-201610001-00468.Peer-Reviewed Original ResearchDaily proton pump inhibitorProton pump inhibitors
2013
Su1272 Proton Pump Inhibitor and Risk of Microscopic Colitis: A Meta-Analysis of Epidemiologic Evidence
Devaki P, Nangia S, Marupakula V, Njei B, Ditah I, Ehrinpreis M. Su1272 Proton Pump Inhibitor and Risk of Microscopic Colitis: A Meta-Analysis of Epidemiologic Evidence. Gastroenterology 2013, 144: s-444. DOI: 10.1016/s0016-5085(13)61639-x.Peer-Reviewed Original ResearchRisk of microscopic colitisEpidemiological evidenceMeta-analysisProton pump inhibitorsMicroscopic colitis
2011
Proton Pump Inhibitors (PPIs) Versus H2-Receptor Antagonists (H2RAs) for Functional Dyspepsia: A Meta-analysis of Randomized Controlled Trials
Njei B, Ditah I, Ngu J, Njei N, Tita A. Proton Pump Inhibitors (PPIs) Versus H2-Receptor Antagonists (H2RAs) for Functional Dyspepsia: A Meta-analysis of Randomized Controlled Trials. The American Journal Of Gastroenterology 2011, 106: s497. DOI: 10.14309/00000434-201110002-01306.Peer-Reviewed Original Research
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply